Zimmer Biomet Holdings ROA 2006-2018 | ZBH

Current and historical return on assets (ROA) values for Zimmer Biomet Holdings (ZBH) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Zimmer Biomet Holdings ROA for the three months ending December 31, 2018 was 6.13%.
Zimmer Biomet Holdings ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2018-12-31 $-0.38B $24.13B -1.48%
2018-09-30 $1.75B $25.38B 6.74%
2018-06-30 $1.69B $25.49B 6.43%
2018-03-31 $1.69B $27.18B 6.37%
2017-12-31 $1.81B $26.01B 6.85%
2017-09-30 $0.65B $26.42B 2.45%
2017-06-30 $0.71B $26.46B 2.66%
2017-03-31 $0.50B $26.99B 1.86%
2016-12-31 $0.31B $26.68B 1.16%
2016-09-30 $0.36B $27.04B 1.37%
2016-06-30 $0.23B $25.97B 0.86%
2016-03-31 $0.08B $26.30B 0.31%
2015-12-31 $0.15B $27.16B 0.59%
2015-09-30 $0.17B $26.69B 0.83%
2015-06-30 $0.32B $27.20B 2.00%
2015-03-31 $0.67B $17.19B 5.81%
2014-12-31 $0.72B $9.66B 7.52%
2014-09-30 $0.83B $9.67B 8.64%
2014-06-30 $0.81B $9.64B 8.52%
2014-03-31 $0.78B $9.38B 8.37%
2013-12-31 $0.78B $9.58B 8.48%
2013-09-30 $0.68B $9.36B 7.49%
2013-06-30 $0.70B $9.10B 7.88%
2013-03-31 $0.77B $8.75B 8.70%
2012-12-31 $0.76B $9.01B 8.64%
2012-09-30 $0.76B $8.78B 8.81%
2012-06-30 $0.77B $8.62B 9.12%
2012-03-31 $0.76B $8.60B 9.09%
2011-12-31 $0.76B $8.52B 9.21%
2011-09-30 $0.64B $8.20B 7.86%
2011-06-30 $0.64B $8.25B 7.90%
2011-03-31 $0.60B $8.12B 7.52%
2010-12-31 $0.60B $8.00B 7.54%
2010-09-30 $0.72B $8.00B 9.12%
2010-06-30 $0.68B $7.83B 8.70%
2010-03-31 $0.72B $7.82B 9.38%
2009-12-31 $0.72B $7.79B 9.52%
2009-09-30 $0.73B $7.65B 9.87%
2009-06-30 $0.80B $7.46B 10.96%
2009-03-31 $0.81B $7.23B 11.40%
2008-12-31 $0.85B $7.24B 12.05%
2008-09-30 $0.95B $7.08B 13.71%
2008-06-30 $0.78B $6.94B 11.54%
2008-03-31 $0.78B $6.92B 11.89%
2007-12-31 $0.77B $6.63B 12.18%
2007-09-30 $0.76B $6.37B 12.20%
2007-06-30 $0.89B $6.32B 14.70%
2007-03-31 $0.86B $6.10B 14.40%
2006-12-31 $0.84B $5.97B 14.05%
2006-09-30 $0.79B $5.91B 13.44%
2006-06-30 $0.78B $5.96B 13.36%
2006-03-31 $0.77B $5.92B 13.43%
2005-12-31 $0.73B $5.72B 13.06%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $25.222B $7.933B
Zimmer Biomet Holdings, Inc. is a musculoskeletal healthcare company. The company design, manufacture and market orthopaedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants; and related surgical products. Zimmer Biomet Holdings, Inc., formerly known as Zimmer Holdings, Inc., is based in Warsaw, United States.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $132.164B 26.13
Medtronic (MDT) Ireland $123.923B 18.53
Stryker (SYK) United States $69.625B 25.56
Boston Scientific (BSX) United States $55.366B 27.03
Baxter (BAX) United States $39.075B 24.08
Smith & Nephew SNATS (SNN) United Kingdom $16.659B 0.00
ResMed (RMD) United States $14.394B 27.30
Canopy Growth (CGC) Canada $11.042B 0.00
Bio-Rad Laboratories (BIO) United States $8.100B 51.79
Aurora Cannabis (ACB) Canada $7.040B 50.36
Hill-Rom Holdings (HRC) United States $6.974B 21.57
Perrigo (PRGO) Ireland $6.650B 10.09
Insulet (PODD) United States $5.226B 0.00
ICU Medical (ICUI) United States $5.189B 28.91
GW Pharmaceuticals (GWPH) United Kingdom $4.539B 0.00
Haemonetics (HAE) United States $4.489B 39.82
Agios Pharmaceuticals (AGIO) United States $3.449B 0.00
Hutchison China MediTech (HCM) China $3.417B 0.00
Neogen (NEOG) United States $3.281B 50.39
NuVasive (NUVA) United States $3.013B 28.03
National Vision Holdings (EYE) United States $2.624B 50.75
Quidel (QDEL) United States $2.574B 23.28
Aphria (APHA) $2.402B 106.67
NxStage Medical (NXTM) United States $1.954B 0.00
AtriCure (ATRC) United States $1.279B 0.00
Phibro Animal Health (PAHC) United States $1.231B 17.70
VAREX IMAGING (VREX) United States $1.198B 23.45
Cardiovascular Systems (CSII) United States $1.170B 840.00
HEXO (HEXO) $1.156B 0.00
MacroGenics (MGNX) United States $0.923B 0.00
Cerus (CERS) United States $0.878B 0.00
PetIQ (PETQ) United States $0.837B 21.68
Surmodics (SRDX) United States $0.766B 111.39
Evolus (EOLS) United States $0.747B 0.00
NanoString Technologies (NSTG) United States $0.719B 0.00
Lantheus Holdings (LNTH) United States $0.713B 22.07
Meridian Bioscience (VIVO) United States $0.704B 20.97
OraSure Technologies (OSUR) United States $0.703B 31.03
Omeros (OMER) United States $0.688B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.625B 20.05
Quanterix (QTRX) United States $0.505B 0.00
LeMaitre Vascular (LMAT) United States $0.492B 24.18
Owens & Minor (OMI) United States $0.479B 5.42
TG Therapeutics (TGTX) United States $0.395B 0.00
Insys Therapeutics (INSY) United States $0.368B 0.00
Utah Medical Products (UTMD) United States $0.334B 21.65
BioLife Solutions (BLFS) United States $0.299B 404.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.293B 0.00
Bovie Medical (APYX) United States $0.279B 0.00
Vapotherm (VAPO) United States $0.276B 0.00
Cytosorbents (CTSO) United States $0.262B 0.00
Rockwell Medical (RMTI) United States $0.242B 0.00
Zynex (ZYXI) United States $0.165B 15.97
Surface Oncology (SURF) United States $0.150B 0.00
Fonar (FONR) United States $0.143B 7.65
Chembio Diagnostics (CEMI) United States $0.119B 0.00
Chimerix (CMRX) United States $0.101B 0.00
United-Guardian (UG) United States $0.091B 18.98
Female Health (VERU) United States $0.084B 0.00
InfuSystems Holdings (INFU) United States $0.081B 0.00
CAS Medical Systems (CASM) United States $0.070B 0.00
Trinity Biotech (TRIB) Ireland $0.063B 17.33
Conatus Pharmaceuticals (CNAT) United States $0.062B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.056B 0.00
ImmuCell (ICCC) United States $0.038B 0.00
Neurotrope (NTRP) United States $0.034B 0.00
Senestech (SNES) United States $0.021B 0.00
Myomo (MYO) United States $0.016B 0.00
Capricor Therapeutics (CAPR) United States $0.013B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.013B 0.00
Akers Biosciences Inc (AKER) United States $0.011B 0.00
Valeritas Holdings (VLRX) United States $0.010B 0.00
Cellectar Biosciences (CLRB) United States $0.009B 0.00
NeuroMetrix (NURO) United States $0.007B 13.57